Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-19-018733
Date:2019-05-14
Issuer: HAEMONETICS CORP (HAE)
Original Submission Date:

Reporting Person:

BASIL MICHELLE L
400 WOOD ROAD
BRAINTREE, MA 02184

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-14 A 2,805 a $0.00 15,684 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 98.025 2019-05-14 deemed execution date A 9,794 (a) 2026-05-14 common stock 9,794 $98.03 9,794 direct
Footnotes
IDfootnote
f1 the securities awarded are in the form of restricted stock units ("rsus") issued pursuant to the haemonetics corporation 2005 long-term incentive compensation plan (as amended). the rsus vest in annual increments of 25% beginning on the first anniversary of the date of grant.
f2 each rsu represents a contingent right to receive one (1) share of the issuer's common stock when vested.
f3 this number includes unvested rsus previously reported.
f4 option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
WhaleWisdom Logo

Elevate your investments